The authors describe three cases of patients with bilateral keratoconus. The clinical evolution, tomographic features and the different therapeutic options selected in accordance with the evolution of the disease over the course of 10 years of follow-up are discussed. A periodic follow-up of patients with keratoconus allows planning the most appropriate therapy according to the evolutionary stage of the disease.
INTRODUCTION
Keratoconus (KC) is a noninflammatory corneal ectasia, usually bilateral and asymmetric, with progressive corneal thinning and steepening that induces an irregular astigmatism and decreased visual acuity (VA). The symptoms are highly variable and depend on the stage of progression. At the beginning of the disease, there may be no symptoms, but latter there is a significant distortion of vision, accompanied by profound visual loss.
1,2 KC treatment depends on its stage. In the initial stage, glasses correct astigmatism satisfactorily, but as the disease progresses vision is best corrected by contact lenses which promote keratic flattening. 3 When contact lenses are no longer effective or poorly tolerated, there are surgical alternatives such as intracorneal ring segments, corneal collagen crosslinking (CXL) or corneal transplant. 
DISCUSSION
KC is the most common corneal dystrophy. It is a process of progressive corneal thinning that causes irregular astigmatism. Most cases are bilateral, but usually one eye is more severely affected.
1,2
Patients with KC usually present in their twenties, with complaints of progressive blurred and distorted vision, secondary to high myopia and astigmatism. Retinoscopy usually shows a 'scissoring' of the red reflex. Rizzuti sign, Fleischer ring or Vogt lines can also be found. In advanced For evaluation purposes, corneal tomography is a valuable tool to diagnose subclinical KC as well as to track the disease progression.
Reduced VA due to KC can initially be treated with glasses. However, contact lenses often provide better vision, by promoting flattening of the cornea and obliteration of the irregular astigmatism. There are several types of contact lenses and the goal is always to provide the best possible VA with maximum comfort. 3 Patients intolerant to contact lenses have several surgical alternatives and the choice should be made on an individual basis, in order to perform the most appropriate therapy for each case. When the central cornea is clear they can benefit with intracorneal ring segments placement to correct the irregular astigmatism. 4, 5 CXL is a promising approach for treating KC, which is based on the combined use of the photosensitizer drug riboflavin and 370 nm UVA light. CXL is the only available treatment directed to the KC pathophysiology, to 'normalize' the biomechanical and structural stromal instability. [6] [7] [8] When corneal scarring involving the visual axis or a progressive thinning of the cornea is present, penetrating or lamellar keratoplasty may be the preferred choice. 10 All three patients presented initially a KC in different evolutive stages and with variable VA. During the follow-up there was a progression of the disease, with reduction of VA according to the level of corneal involvements and eventually intolerance to contact lenses. Consequently, the different treatments available were performed in a temporal sequence appropriate to the stage of the disease and patient complaints.
CONCLUSION
Periodic follow-up of patients with KC is important, since it is a progressive ectasia which requires regular and thorough assessment of corneal health. Regular monitoring allows the most appropriate therapy directed to the stage of the disease as well as the characteristics of each case. 
